Skip Navigation

Jeffery Michael Coller, Ph.D.

Headshot of Jeffery Michael Coller
  • Bloomberg Distinguished Professor of RNA Biology and Therapeutics
  • Professor of Molecular Biology and Genetics

Research Interests

Messenger RNA Translation and Stability


Jeffery Coller has made seminal discoveries in the area of messenger RNA stability and translation. Working from ribosomes to patients, he is pushing open this exciting field with the aim of developing novel therapeutics for devastating rare diseases, improving gene therapy manufacturing and efficacy, and exploring novel disease diagnostics.

Coller studies the very essence of life: translation of the genetic code. His work has led to fundamental shifts in the understanding of gene expression by demonstrating that the genetic code is a major determinant of mRNA fate in eukaryotes, including humans. Coller examines the relationship between mRNA translation—a process in which messenger RNA is synthesized into a protein—and mRNA stability, focusing in particular on the pathways underlying mRNA degradation. He investigates what exactly signals the end of mRNA translation and the beginning of mRNA degradation, which is not yet understood but holds great potential for novel therapeutics.

Coller joined Johns Hopkins University as a Bloomberg Distinguished Professor in 2020 from Case Western Reserve University. more


  • Bloomberg Distinguished Professor of RNA Biology and Therapeutics
  • Professor of Molecular Biology and Genetics

Departments / Divisions



  • B.S.; University of Michigan (Michigan) (1994)
  • Ph.D.; University of Wisconsin (Wisconsin) (2000)

Research & Publications


Lab Website: Coller Lab

Technology Expertise Keywords

RNA Therapeutics

Contact for Research Inquiries

725 N. Wolfe St.
PCTB 503
Baltimore, MD 21205-2105 map

Academic Affiliations & Courses

Graduate Program Affiliation


Human Medical Genetics

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button